Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

Name: Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer
Published: 2001
License: Public Domain

UNC Lineberger Comprehensive Cancer Center · 2001

ClinicalTrials.gov · Datasets · License: Public Domain · 2001

Open Source ↗

breast-cancer leukemia lymphoma ovarian-cancer

breast cancer, leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, ovarian cancer, unspecified adult solid tumor, protocol specific, stage iiia breast cancer, stage iiib breast cancer, stage iiic breast cancer, stage iv breast cancer, male breast cancer, recurrent ovarian epithelial cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 852772
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.